Older adults with cancer heterogeneously experience health care, treatment, and symptoms.
Geriatric assessment (GA) offers a comprehensive evaluation of an older individual's health …

Myelodysplastic syndromes/neoplasms (MDS) and related diseases are highly
heterogeneous myeloid stem cell cancers that predominantly affect the elderly. The only …

The Oncology Grand Rounds series is designed to place original reports published in the
Journal into clinical context. A case presentation is followed by a description of diagnostic …

Among the potential complications of allogeneic hematopoietic stem cell transplantation
(HSCT), graft-versus-host disease (GVHD) is common and associated with significant …

The advent of reduced-intensity conditioning regimens, improvements in graft-versus-host
disease prophylaxis, and better supportive care have permitted increasing use of allogeneic …

Hematologic malignancies most often present in the sixth or seventh decade of life. Even so,
many older adults may be unable to tolerate standard chemotherapy or require …

Allogeneic hematopoietic cell transplantation (HCT) is no longer exclusively for the young.
With an aging population, development of non‐intensive remission‐inducing strategies for …

Abstract Purpose of Review To highlight the priorities in geriatric assessment research in
myeloid malignancies and discuss design considerations necessary to ensure research is …

In this issue of Blood Advances, Nagler et al 1 report that outcomes are similar for patients
with secondary acute myeloid leukemia (sAML) compared with those with de novo AML …

Background Allogeneic hematopoietic cell transplantation (allo-HCT) is a potential cure for
many hematological malignancies. Historically, older adults were not considered eligible for …